Bone disease in cirrhosis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

1. AASLD AST Practice Guideline on adult liver transplantation: Candidate evaluation.Hepatology (Baltimore, Md.) · 2026
   Guideline
2. Prevalent osteoporosis and fracture risk in patients with hepatic cirrhosis: a systematic review and meta-analysis.BMC gastroenterology · 2025
   Pooled it
3. Side Effects of Immunosuppressant Drugs After Liver Transplant.Pharmaceuticals (Basel, Switzerland) · 2025
   Review
4. High bone fracture risk in a large modern cohort of liver transplant recipients.Internal and emergency medicine · 2025
   Article
5. From liver to hormones: The endocrine consequences of cirrhosis.World journal of gastroenterology · 2024
   Review
6. Osteoporosis and Fragility Fractures in Patients with Liver Cirrhosis: Usefulness of FRAXJournal of clinical medicine · 2023
   Article
7. Vitamin D status & bone health in patients with liver cirrhosis.The Indian journal of medical research · 2023
   Article
8. Evaluation and Management of Chronic Cholestatic Liver Diseases.Middle East journal of digestive diseases · 2023
   Review
9. Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response.World journal of hepatology · 2022
   Review
10. A narrative review of nutritional abnormalities, complications, and optimization in the cirrhotic patient.Translational gastroenterology and hepatology · 2022
    Review
11. [Liver cirrhosis and secondary osteoporosis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
    Review
12. Macrophage-Stimulating Protein Enhances Osteoblastic Differentiation via the Recepteur d'Origine Nantais Receptor and Extracellular Signal-Regulated Kinase Signaling Pathway.Journal of bone metabolism · 2020
    Article
13. Effect of levocarnitine administration in patients with chronic liver disease.Experimental and therapeutic medicine · 2020
    Article
14. Oro-Dental Health of Patients with Chronic Hepatic Failure.International journal of organ transplantation medicine · 2020
    Article
15. Nutritional Challenges in Patients with Advanced Liver Cirrhosis.Journal of clinical medicine · 2019
    Review
16. Bone Diseases in Patients with Chronic Liver Disease.International journal of molecular sciences · 2019
    Review
17. Suboptimal Level of Bone-Forming Cells in Advanced Cirrhosis are Associated with Hepatic Osteodystrophy.Hepatology communications · 2018
    Article
18. Osteoporosis and Jaw Abnormalities in Panoramic Radiography of Chronic Liver Failure Patients.BioMed research international · 2018
    Article
19. Nutritional Management of a Liver Transplant Candidate.Journal of clinical and experimental hepatology
    Review
20. Sarcopenia in the Cirrhotic Patient: Current Knowledge and Future Directions.Journal of clinical and experimental hepatology
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.